No additional studies are currently planned for arterial stiffness in COPD patients with
fluticasone furoate and vilanterol.
Where Additional Information Can Be Found
Clinical studies have unique study numbers which are included in publications and other
information about the study. Below are the unique study numbers associated with this
study. The hyperlink text connects to scientific summaries and other information on the
Internet.*
Organization Website Study Number
European Medicines www.clinicaltrialsregister.eu 2010-023091-10
Agency
US National Institutes www.clinicaltrials.gov NCT01336608
of Heath (NIH)
GlaxoSmithKline www.gsk.clinicalstudyregister.com HZC113108
(GSK)
Your doctor can help you understand more about this study and the results. You should
not make changes to your care based on the results of this or any single study. Maintain
your current treatment unless instructed by your doctor.
This document was developed and approved by GSK on 9 December 2016. The information
in this summary does not include additional information available after this date.
* If you are reading this document in hard copy and cannot access the websites through the hyperlinks
embedded in this document, you can type the following web addresses in your browsers.
EudraCT summary: https://www.clinicaltrialsregister.eu/ctr-search/search?query=2010-023091-10
US NIH/clinicaltrials.gov: https://clinicaltrials.gov/ct2/results?term=113108&Search=Search
GSK Clinical Study Register: http://www.gsk-clinicalstudyregister.com/search/?study_ids=113108#